Try our Advanced Search for more refined results
Health
-
March 16, 2026
Defamation Suit Against WWE Accuser's Lawyer Advances
A Connecticut federal judge on Friday refused to toss a doctor's defamation suit against the Holland Law Firm and one of its attorneys, saying it is premature to determine whether the plaintiff, whose patient accuses the former CEO of World Wrestling Entertainment Inc. of sex trafficking, is a public figure who has to prove actual malice.
-
March 16, 2026
Judge Tosses Kaiser Whistleblowers' Claims After $556M Deal
A California federal court on Monday officially dismissed False Claims Act lawsuits from the federal government and three people alleging that Kaiser Permanente affiliates engaged in Medicare fraud, on the heels of Kaiser's $556 million settlement reached in January.
-
March 16, 2026
Pa. Appeals Court Reinstates Kratom And Caffeine DUI Charge
A man charged with driving under the influence and other offenses after using caffeine and the herbal stimulant kratom cannot argue his case should be dismissed since he wasn't using controlled substances, the Pennsylvania Superior Court said Monday, reversing a lower court.
-
March 16, 2026
J&J's Lack Of Malice Gets $966M Talc Verdict Cut To $16M
A California state judge slashed $950 million in punitive damages from a $966 million jury verdict against Johnson & Johnson on Friday in a lawsuit involving an 88-year-old woman who died of mesothelioma, saying the estate's counsel failed to sufficiently show the pharmaceutical giant acted maliciously.
-
March 16, 2026
Mich. Jury Awards $10M To Med Resident Fired During Leave
A Michigan state jury has awarded more than $10 million to a former medical student who said she was fired from a hospital's OB-GYN residency program after being forced to take a required licensing exam while on maternity leave.
-
March 16, 2026
Medtronic Seeks To Ax 'Extreme Outlier' $382M Antitrust Loss
Medtronic has urged a California federal judge to scrap its nearly $382 million trial loss to rival Applied Medical over Medtronic's bundling practices that a jury found suppressed competition for advanced bipolar devices, arguing the verdict is an "extreme outlier" in antitrust law that can't survive.
-
March 16, 2026
HHS' Childhood Vaccine Policy Changes Put On Ice
A Massachusetts federal judge on Monday blocked the Trump administration's modified childhood vaccine schedule and put all decisions made by Health Secretary Robert F. Kennedy Jr.'s federal vaccine policy committee on hold, finding they veered sharply from normal procedure and likely violated the law.
-
March 16, 2026
Incentive Pay Boosted Cigna GC To $5.96 Million In 2025
A boost in incentive pay helped raise the total compensation of Cigna Group's general counsel to nearly $5.96 million in 2025, according to a recent securities filing.
-
March 16, 2026
GAO Rejects Unequal Evaluation Claim In CMS Contract
The U.S. Government Accountability Office found the Centers for Medicare and Medicaid Services did not treat a technology contractor unequally by giving it a low-confidence rating in the technical category even though the winning bidder had time-management issues.
-
March 16, 2026
Triton Clinches €5.5B For 6th Fund In Largest Raise To Date
European middle-market private equity shop Triton Partners, led by Simpson Thacher & Bartlett LLP, on Monday revealed that it closed its sixth flagship mid-market fund with €5.5 billion ($6.3 billion) in tow, marking the firm's largest fundraise to date.
-
March 16, 2026
Senior Housing REIT Janus Living Seeks $703M From IPO
Senior housing-focused real estate investment trust Janus Living said Monday that it is seeking about $700 million in an initial public offering this week, advised by Latham & Watkins LLP and Sidley Austin LLP, that follows a carveout this year.
-
March 16, 2026
Mass. City Accused Of Bias In Mental Health 911 Response
The city of Worcester, Massachusetts, was hit with a suit Monday claiming that its 911 response is inadequate and discriminatory towards people with mental disabilities because the armed police who usually show up are ill-equipped to deal with those calls and often make matters worse.
-
March 13, 2026
'Swinging Dicks' Dissent Stirs Uproar Across 9th Circ. Bench
A raunchy dissent in litigation over transgender spa patrons prompted dozens of Ninth Circuit judges to denounce the "vulgar barroom talk" of a colleague, who returned fire by ridiculing his peers for adopting the "fastidious sensibilities of a Victorian nun."
-
March 13, 2026
Cannabis Co. Loses Bid To Merge Rival's Suit With AI Fight
A Florida federal judge has found "there is no basis to consolidate" two lawsuits between medical marijuana company Leafwell and its competitor My Florida Green, concluding Leafwell's lawsuit accusing My Florida Green's counsel of misusing artificial intelligence to wreck Leafwell's business doesn't substantially overlap with My Florida Green's unfair business practice suit against Leafwell and others.
-
March 13, 2026
Maryland Bros. Get Prison For HIV Drug Fraud Scheme
A Florida federal judge on Friday sentenced two Maryland brothers to prison for their roles in a fraudulent medication scheme that involved selling misbranded HIV drugs with fake tracing documents to pharmacies and patients.
-
March 13, 2026
4th Circ. Brings Back Allergan Medicaid Overcharging Suit
A split Fourth Circuit panel on Friday revived a whistleblower suit accusing an Allergan Sales LLC predecessor of overcharging Medicaid by more than $680 million, saying the whistleblower plausibly alleged the company knowingly improperly aggregated discounts into "best prices" for drugs.
-
March 13, 2026
Conn. Statehouse Catch-Up: AI, Social Media, Private Equity
Connecticut lawmakers are one-third of the way through the state's three-month legislative session, and already, bills targeting social media, artificial intelligence, prediction markets, private equity and hospital ownership are stacking up at the statehouse.
-
March 13, 2026
Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar
Sandoz Inc. is appealing after a Virginia federal court ruled it should have brought claims accusing Amgen of blocking competition for the Enbrel biosimilar in a previous patent dispute, according to a Friday notice.
-
March 13, 2026
Voyager Acquisition's 2nd SPAC Seeks To Raise $220M
Special purpose acquisition company Voyager Acquisition II on Friday filed plans with U.S. regulators to raise up to $220 million in an initial public offering, with the goal of merging with an entity in the technology, fintech or healthcare sectors.
-
March 13, 2026
Texas Justices Clear Way For State's Trans Care Probe
An LGBTQ+ advocacy organization must produce documents as part of an investigation from the Texas attorney general's office into transgender treatments for minors, the Texas Supreme Court ruled on Friday, saying that the state's ban on gender-affirming care for minors is the law and must be followed.
-
March 13, 2026
Kroger Agrees To Pay $17M In Drug Copay Inflation Case
Kroger pharmacy customers reached a $17 million settlement with the grocer resolving allegations that it inflated their copays for insured prescriptions, according to a motion for preliminary approval of the deal filed in Ohio federal court.
-
March 13, 2026
J&J Unit Says Ex-Director Misappropriated Trade Secrets
A Johnson & Johnson subsidiary has accused a former associate director of downloading over 7,000 files worth of confidential information prior to her resignation and using it to start her own competing company.
-
March 13, 2026
UK Litigation Roundup: Here's What You Missed In London
In London, Estée Lauder accused Jo Malone's founder of intellectual property infringement, the wife of an Iranian businessman linked to a £75 million fraud sued several Iranian oil companies, HSBC sued U.S. property tycoon Michael Fuchs, and Charles Russell Speechlys brought a claim against a United Arab Emirates company it once represented in an international arbitration.
-
March 13, 2026
Drug Co. Moves To Sanction Insurer Over Destroyed Evidence
A drug wholesaler seeking coverage for underlying opioid litigation urged an Illinois federal court to sanction its insurer for destroying key emails and underwriting records, saying the carrier failed to update a litigation hold or suspend its automatic deletion policies and then attempted to hide the issue during discovery.
-
March 13, 2026
EPA Aims To Lift Biden-Era Ethylene Oxide Limits
The U.S. Environmental Protection Agency on Friday proposed rolling back limits on emissions of ethylene oxide, a carcinogenic chemical used in the sterilization of medical devices.
Expert Analysis
-
Series
Knitting Makes Me A Better Lawyer
Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.
-
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
How MAHA Is Taking Shape At The State Level
The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level actions regarding potential health impacts of certain food ingredients, increasing the difficulty and importance of maintaining effective compliance programs, say attorneys at Cooley.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.
-
Key Takeaways From Armed Services Board's FY 2025 Report
The Armed Services Board of Contract Appeals’ annual report reveals an increase in new cases filed, but a decrease in cases resolved, and fewer parties choosing alternative dispute resolution, despite the likely reduction in time and expenses incurred during a prolonged appeal process, say attorneys at Miller & Chevalier.
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
New Drug Ad Regs Could Lead To A Less Informed Public
A federal push to mandate full safety warnings in pharmaceutical advertising could make drug ads less appealing for companies to air, which in turn could negatively affect consumers' health decisions by removing an accessible information source, say Punam Keller at Dartmouth College and Ceren Canal Aruoba at Berkeley Research Group.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
A Look At Middlemen Fees In 340B Drug Discount Program
A U.S. Senate committee's recent hearing on the Section 340B drug discount program, along with statistical analysis of payment amounts, contribute to a growing consensus that middlemen fees are too high, say William Sarraille at the University of Maryland, and Shanyue Zeng and Rory Martin at IQVIA.
-
Series
Law School's Missed Lessons: Practicing Client-Led Litigation
New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.
-
Perspectives
Nursing Home Abuse Cases Face 3 Barriers That Need Reform
Recent headlines reveal persistent gaps in oversight and protection for vulnerable residents in long-term care, but prosecution of these cases is often stymied by numerous challenges that will require a comprehensive overhaul of regulatory, legal and financial structures to address, says Veronica Finkelstein at Wilmington University.
-
Series
The Law Firm Merger Diaries: How To Build On Cultural Fit
Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.